What is Mukdahan International Hospital PCL EBITDA Margin %?
Mukdahan International Hospital PCLBKK:HANN +1.14%17 EBITDA Margin % is 11.60% as of Mar. 2026, which is 19% below its 10-year median of 14.35. GuruFocus rates BKK:HANN with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Mukdahan International Hospital PCL ranks better than 51.81% on this metric.
Mukdahan International Hospital PCL (BKK:HANN) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Mukdahan International Hospital PCL EBITDA Margin % Related Terms
Mukdahan International Hospital PCL EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mukdahan International Hospital PCL EBITDA Margin % Chart
Mukdahan International Hospital PCL Annual Data
Trend
Dec23
Dec24
Dec25
EBITDA Margin %
17.20
14.35
12.67
Mukdahan International Hospital PCL Quarterly Data
BKK:HANN vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Mukdahan International Hospital PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mukdahan International Hospital PCL EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mukdahan International Hospital PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Mukdahan International Hospital PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mukdahan International Hospital PCL (BKK:HANN) has a EBITDA Margin % of 11.60% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Mukdahan International Hospital PCL and its competitors. This is 19% below median its historical median of 14.35. Over the past decade, Mukdahan International Hospital PCL's EBITDA Margin % has ranged from 10.69 to 17.20. According to the industry distribution chart, Mukdahan International Hospital PCL ranks #320 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 48.2%.
Is Mukdahan International Hospital PCL's EBITDA Margin % too high?
Mukdahan International Hospital PCL's current EBITDA Margin % of 11.60% is 19% below median its 10-year median of 14.35. Over the past 10 years, this metric has ranged from a low of 10.69 to a high of 17.20. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Mukdahan International Hospital PCL's value of 11.60% is 13.6% above this industry median. Based on the distribution chart, Mukdahan International Hospital PCL ranks #320 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Mukdahan International Hospital PCL has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Mukdahan International Hospital PCL's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Mukdahan International Hospital PCL ranks #320 out of 664 companies for EBITDA Margin %. This puts Mukdahan International Hospital PCL in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Mukdahan International Hospital PCL's value of 11.60% is 13.6% above this benchmark. Historically, Mukdahan International Hospital PCL's own EBITDA Margin % has ranged from 10.69 to 17.20 over the past decade. While the company's 10-year median is 14.35 vs. the industry median of 10.21, Mukdahan International Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mukdahan International Hospital PCL's current EBITDA Margin % of 11.60% is 13.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Mukdahan International Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mukdahan International Hospital PCL's current EBITDA Margin % is 11.60%, which is 19% below median its own 10-year median of 14.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mukdahan International Hospital PCL stock overvalued right now?
Mukdahan International Hospital PCL (BKK:HANN) has a current EBITDA Margin % of 11.60%. The current EBITDA Margin % is 11.60%, which is 19% below median its 10-year median of 14.35 and 13.6% above the Healthcare Providers & Services industry median of 10.21. Mukdahan International Hospital PCL's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Mukdahan International Hospital PCL (BKK:HANN), the current EBITDA Margin % is 11.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mukdahan International Hospital PCL Business Description
Mukdahan International Hospital PCL is engaged in providing comprehensive treatment services for a wide range of specialized diseases. There are three private hospitals under the company group, namely: Mukdahan International Hospital, Dr. Han Hospital, and Ruam Phaet Yasothon Hospital, which provide comprehensive services over 16 medical centers and clinics.
17GF Score
Get the complete analysis for BKK:HANN
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:HANN has been successfully added to your 
